TDRD7_HUMAN: A Potential Drug Target Or Biomarker (G23424)

Target Name: TDRD7

NCBI ID: G23424

TDRD7

TDRD7_HUMAN: A Potential Drug Target Or Biomarker

TDRD7 (TDRD7_HUMAN) is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker. It is a member of the TDRD7 family, which is known for its role in the development and progression of various diseases, including cancer.

The TDRD7 family consists of four proteins: TDRD7, TDRD7-ASK, TDRD7-ASP, and TDRD7-PHF2. These proteins are involved in a variety of cellular processes, including cell signaling, DNA replication, and apoptosis. They are also involved in the development and progression of various diseases, including cancer.

One of the proteins in the TDRD7 family is TDRD7_HUMAN. TDRD7_HUMAN is a 21-kDa protein that is expressed in various human tissues, including muscle, pancreas, and brain. It is highly conserved, with a calculated pI of 1.15 and a predicted hydrophobicity of 0.42.

TDRD7_HUMAN has been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of TDRD7_HUMAN are associated with poor prognosis in patients with pancreatic ductal adenocarcinoma, a type of cancer that arises from the ducts that carry bile from the pancreas to the small intestine.

In addition to its potential role in cancer, TDRD7_HUMAN is also involved in the development and progression of other diseases. For example, studies have shown that TDRD7_HUMAN is involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Given its potential role in the development and progression of various diseases, TDRD7_HUMAN is a promising drug target or biomarker. Researchers are currently studying the effects of drugs that target TDRD7_HUMAN to see if they can be used to treat or diagnose various diseases.

In conclusion, TDRD7_HUMAN is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker. Its role in the development and progression of various diseases makes it an attractive target for research and treatment. Further studies are needed to fully understand the effects of drugs that target TDRD7_HUMAN.

Protein Name: Tudor Domain Containing 7

Functions: Component of specific cytoplasmic RNA granules involved in post-transcriptional regulation of specific genes: probably acts by binding to specific mRNAs and regulating their translation. Required for lens transparency during lens development, by regulating translation of genes such as CRYBB3 and HSPB1 in the developing lens. Also required during spermatogenesis

The "TDRD7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TDRD7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets